½ÃÀ庸°í¼­
»óǰÄÚµå
1524833

¼¼°èÀÇ ½Ä¿å¾ïÁ¦Á¦ ½ÃÀå(2024-2028³â)

Global anorexiants market 2024-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechNavio | ÆäÀÌÁö Á¤º¸: ¿µ¹® 138 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½Ä¿å¾ïÁ¦Á¦ ½ÃÀåÀº 2023-2028³â 10¾ï 2,340¸¸ ´Þ·¯·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 4.5%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ½Ä¿å¾ïÁ¦Á¦ ½ÃÀå¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ Æ÷ÇÔÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ºñ¸¸ Àα¸ÀÇ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎÀÇ ³ë·Â Áõ°¡, º´¿ë ¿ä¹ý °³¹ß µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2024
Á¾·á ¿¬µµ 2028
¿¹Ãø ±â°£ 2024-2028
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â ´ëºñ 2024³â 4.23%
CAGR 4.5%
ÁõºÐ ±Ý¾× 10¾ï 2,340¸¸ ´Þ·¯

ÀÌ º¸°í¼­´Â ÇâÈÄ ¸î ³â µ¿¾È ½Ä¿å¾ïÁ¦Á¦ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÒ ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ½Å¾àÀÇ ¿¬±¸¿Í ½ÂÀÎÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, üÁß °ü¸®¿¡ ´ëÇÑ Àνİú ¼Ò¾Æºñ¸¸ ¹× º´Àû ºñ¸¸ ¹ß»ý·üÀÇ Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦2Àå ½ÃÀå »óȲ

  • ½ÃÀå »ýŰè
  • ½ÃÀåÀÇ Æ¯Â¡
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦3Àå ½ÃÀå ±Ô¸ð Æò°¡

  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ºÎ¹® ºÐ¼®
  • ½ÃÀå ±Ô¸ð 2023
  • ½ÃÀå Àü¸Á 2023-2028

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

  • ¼¼°è ½Ä¿å¾ïÁ¦Á¦ ½ÃÀå 2018-2022
  • À¯Åë ä³Îº° ºÎ¹® ºÐ¼® 2018-2022
  • Áö¿ªº° ºÎ¹® ºÐ¼® 2018-2022
  • ±¹°¡º° ºÎ¹® ºÐ¼® 2018-2022

Á¦5Àå Five Forces ºÐ¼®

  • Five Forces ¿ä¾à
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù
  • °æÀïÀÇ À§Çù
  • ½ÃÀå »óȲ

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Åë ä³Îº°

  • ½ÃÀå ¼¼ºÐÈ­
  • ºñ±³ : À¯Åë ä³Îº°
  • º´¿ø ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¼Ò¸Å ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¿Â¶óÀÎ ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ½ÃÀå ±âȸ : À¯Åë ä³Îº°

Á¦7Àå °í°´ »óȲ

  • °í°´ »óȲ °³¿ä

Á¦8Àå Áö¿ªº° »óȲ

  • Áö¿ªº° ¼¼ºÐÈ­
  • Áö¿ªº° ºñ±³
  • ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ½ÃÀå ±âȸ : Áö¿ª »óȲº°

Á¦9Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå °úÁ¦
  • ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
  • ½ÃÀå ±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦10Àå °æÀï »óȲ

  • °³¿ä
  • °æÀï »óȲ
  • È¥¶õ »óȲ
  • ¾÷°è ¸®½ºÅ©

Á¦11Àå °æÀï ºÐ¼®

  • ±â¾÷ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • Epic Pharma LLC
  • F. Hoffmann La Roche Ltd.
  • Intas Pharmaceuticals Ltd.
  • Johnson and Johnson Services Inc.
  • Lannett Co. Inc.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Recordati S.p.A
  • Teva Pharmaceutical Industries Ltd.
  • VIVUS LLC

Á¦12Àå ºÎ·Ï

ksm 24.08.09

The anorexiants market is forecasted to grow by USD 1023.4 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the anorexiants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing obese population, increasing government initiatives for healthcare infrastructure, and development of combination therapies.

Technavio's anorexiants market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20244.23%
CAGR4.5%
Incremental Value$1023.4mn

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the research and approval of new drugs as one of the prime reasons driving the anorexiants market growth during the next few years. Also, awareness about weight management and increase in childhood obesity and morbid obesity incidence will lead to sizable demand in the market.

The report on the anorexiants market covers the following areas:

  • Anorexiants market sizing
  • Anorexiants market forecast
  • Anorexiants market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anorexiants market vendors that include Bausch Health Companies Inc., Currax Pharmaceuticals LLC, Elite Pharmaceuticals Inc., Epic Pharma LLC, F. Hoffmann La Roche Ltd., Hi Tech Pharmaceuticals, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., KVK Tech Inc., Lannett Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., Recordati S.p.A, Searchlight Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Virtus Nutrition LLC, VIVUS LLC, and Zydus Lifesciences Ltd.. Also, the anorexiants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Anorexiants Market 2018 - 2022
    • Historic Market Size - Data Table on Global Anorexiants Market 2018 - 2022 ($ million)
  • 4.2 Distribution Channel segment analysis 2018 - 2022
    • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • 4.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
    • Chart on Distribution Channel - Market share 2023-2028 (%)
    • Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 6.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 6.3 Hospital pharmacy - Market size and forecast 2023-2028
    • Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.4 Retail pharmacy - Market size and forecast 2023-2028
    • Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
    • Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
    • Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.5 Online pharmacy - Market size and forecast 2023-2028
    • Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
    • Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
    • Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

7 Customer Landscape

  • 7.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 8.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 8.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 8.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 8.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 8.8 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 8.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 8.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 8.11 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 8.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 9.4 Market opportunities/restraints

10 Competitive Landscape

  • 10.1 Overview
  • 10.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 10.3 Landscape disruption
    • Overview on factors of disruption
  • 10.4 Industry risks
    • Impact of key risks on business

11 Competitive Analysis

  • 11.1 Companies profiled
    • Companies covered
  • 11.2 Market positioning of companies
    • Matrix on companies position and classification
  • 11.3 Epic Pharma LLC
    • Epic Pharma LLC - Overview
    • Epic Pharma LLC - Product / Service
    • Epic Pharma LLC - Key offerings
  • 11.4 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 11.5 Intas Pharmaceuticals Ltd.
    • Intas Pharmaceuticals Ltd. - Overview
    • Intas Pharmaceuticals Ltd. - Product / Service
    • Intas Pharmaceuticals Ltd. - Key offerings
  • 11.6 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
  • 11.7 Lannett Co. Inc.
    • Lannett Co. Inc. - Overview
    • Lannett Co. Inc. - Product / Service
    • Lannett Co. Inc. - Key offerings
  • 11.8 Novo Nordisk AS
    • Novo Nordisk AS - Overview
    • Novo Nordisk AS - Business segments
    • Novo Nordisk AS - Key news
    • Novo Nordisk AS - Key offerings
    • Novo Nordisk AS - Segment focus
  • 11.9 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 11.10 Recordati S.p.A
    • Recordati S.p.A - Overview
    • Recordati S.p.A - Business segments
    • Recordati S.p.A - Key offerings
    • Recordati S.p.A - Segment focus
  • 11.11 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
  • 11.12 VIVUS LLC
    • VIVUS LLC - Overview
    • VIVUS LLC - Product / Service
    • VIVUS LLC - Key offerings

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 12.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 12.4 Research methodology
    • Research methodology
  • 12.5 Data procurement
    • Information sources
  • 12.6 Data validation
    • Data validation
  • 12.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 12.8 Data synthesis
    • Data synthesis
  • 12.9 360 degree market analysis
    • 360 degree market analysis
  • 12.10 List of abbreviations
    • List of abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦